LongeCity Newsletter
July
2017
fundraiser: AgeMeter
A new fundraiser has been launched on the lifespan.io platform, aiming at developing a diagnostic system to measure human functional age in comparison to chronological age, and assist in the assessment of anti-aging therapeutics.
LongeCity has reviewed the project under the Community Fundraiser Programme, and endorses it as a reputable initiative in line with its mission.
We have begun a ⇒ members consultation regarding ways that we can support this project further.
Geroprotector Review: Rapamycin and other mTOR inhibitors
Sven Bulterijs continues his discussion of prominent compounds with potential life extension efficacy by looking not just at rapamycin but also at its target, the mTOR pathway, which has likely a key role in mediating lifespan.
⇒read the article at 'Sven's Science Corner'.
REMINDER: LongeCity is currently running a ⇒'best regimen' competition.
The LongeCity newsletter is usually send out on the 8th or 18th day of each month to registered users.(past newsletters here)
We would love to hear from you.(>LogIn
>Lost Password?)
This newsletter & some of the work of LongeCity was supported by
MitoQ.com- targeting antioxidants directly to mitochondria
CrackAging.com- telomerase activation supplements
⇒
Join as a sponsor or book banner space